In contrast, Nakamura et al. revealed the association of GRX1 with the malignancy of pancreatic ductal carcinoma where the expression of GRX1 was higher than that in pancreatic cystadenocarcinoma or normal pancreas tissue [73]. This evidence concerns the gene GLRX and pancreatic cystadenocarcinoma.